LNC
48
2
NAVI
38
2
AEP
59
5
ZION
49
5
SNA
55
2
WY
40
13
TXN
43
10
NWSA
84
6
INTU
66
-3
EW
38
-2
EMR
50
2
UNH
38
2
NWL
28
-4
PLD
64
3
PM
60
8
GRMN
61
2
VIX
33
3
MRK
53
-11
K
33
3
FTI
79
3
LNC
48
2
NAVI
38
2
AEP
59
5
ZION
49
5
SNA
55
2
WY
40
13
TXN
43
10
NWSA
84
6
INTU
66
-3
EW
38
-2
EMR
50
2
UNH
38
2
NWL
28
-4
PLD
64
3
PM
60
8
GRMN
61
2
VIX
33
3
MRK
53
-11
K
33
3
FTI
79
3
Financhill
Back

Global X Social Media ETF Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Buy
69

SOCL
Global X Social Media ETF

Last Price:
42.37
Seasonality Move:
3.84%
Sell
43

RARE
Ultragenyx Pharmaceutical

Last Price:
39.82
Seasonality Move:
-0.9%
Buy
69
Global X Social Media ETF (SOCL) is a Buy

Is Global X Social Media ETF a Buy, Sell or Hold?

  • The current Global X Social Media ETF [SOCL] share price is $42.25. The Score for SOCL is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.
  • SOCL is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
43
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $39.39. The Score for RARE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

SOCL Stock Price Chart

What is Global X Social Media ETF's stock price today?

  • The Global X Social Media ETF share price today is $42.25
    The current trend is moderately bearish and SOCL is experiencing selling pressure, which indicates risk of future bearish movement.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $39.39
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing selling pressure, which indicates risk of future bearish movement.

SOCL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.05 Sell
Relative Strength Index (14 RSI): 44.97 Sell
Chaikin Money Flow: -3744 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (42.17 - 43.53) Sell
Bollinger Bands (100): (39.37 - 42.83) Buy

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.74 Sell
Relative Strength Index (14 RSI): 45.16 Sell
Chaikin Money Flow: -377368 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (38.89 - 42.13) Sell
Bollinger Bands (100): (40.93 - 48.81) Sell

SOCL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 42.52 Sell
20-day SMA: 42.6 Sell
50-day SMA: 42.16 Buy
200-day SMA: 39.46 Buy
8-day EMA: 42.48 Sell
20-day EMA: 42.64 Sell
50-day EMA: 42.23 Buy
200-day EMA: 40.02 Buy

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 40.13 Sell
20-day SMA: 40.38 Sell
50-day SMA: 41.72 Sell
200-day SMA: 42.46 Sell
8-day EMA: 39.68 Sell
20-day EMA: 40.43 Sell
50-day EMA: 41.92 Sell
200-day EMA: 43.42 Sell

Global X Social Media ETF Earnings Growth & SOCL Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.01 per share, an increase this year of $0.90 per share, and an increase next year of $1.07 per share.

Global X Social Media ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):